The pandemic and the successful Russian vaccine Sputnik V will give the domestic pharmaceutical sector a boost.
There is no question about it, as a high-ranking manager of a well-known European pharmaceutical company says.
He doesn't want to be mentioned by name, so that - as he admits - too much praise from the Russians does not affect business in the USA.